Modelling cumulative exposure for inference about drug effects in observational studies

Author:

Farran Bassam1,McGurnaghan Stuart1,Looker Helen C.2,Livingstone Shona2,Lahnsteiner Eva2,Colhoun Helen M.13ORCID,McKeigue Paul M.4

Affiliation:

1. Institute of Genetics and Molecular Medicine; University of Edinburgh; Edinburgh UK

2. University of Dundee; Dundee UK

3. NHS Fife; Kirkcaldy UK

4. Usher Institute for Population Health Sciences and Informatics; University of Edinburgh; Edinburgh UK

Funder

NHS Research Scotland

Chief Scientist Office of the Scottish Government

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference31 articles.

1. Use of health care databases in pharmacoepidemiology;Hennessy;Basic Clin Pharmacol Toxicol,2006

2. Usefulness of a large automated health records database in pharmacoepidemiology;Hashikata;Environ Health Prev Med,2011

3. Validation of methods to control for immortal time bias in a pharmacoepidemiologic analysis of renin-angiotensin system inhibitors in type 2 diabetes;Yang;J Epidemiol Jpn Epidemiol Assoc,2014

4. Propensity score methods in drug safety studies: practice, strengths and limitations;Wang;Pharmacoepidemiol Drug Saf,2001

5. The environment and disease: association or causation?;Hill;Proc R Soc Med,1965

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3